Asthma, Allergic Completed Phase 1 / 2 Trials for Omalizumab (DB00043)

Also known as: Atopic Asthma / Allergic Asthma / Asthma extrinsic / Extrinsic asthma / Asthma / Asthma, unspecified / Asthma bronchial / Asthma NOS / Asthmatic / Br. asthma / Bronchitic asthma

IndicationStatusPhase
DBCOND0047182 (Asthma, Allergic)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01703312A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic AsthmaTreatment